or Try an Advanced Search...

    Tyrosine Kinase Stocks List

    Symbol Grade Name % Change
    BPMC C Blueprint Medicines Corporation 2.38
    NRIX C Nurix Therapeutics, Inc. 5.42
    BBIO C BridgeBio Pharma, Inc. 2.69
    AVBP D ArriVent BioPharma, Inc. 4.55
    COGT D Cogent Biosciences, Inc. 4.35
    PBYI D Puma Biotechnology Inc -4.86
    EXEL F Exelixis, Inc. 1.02
    RIGL F Rigel Pharmaceuticals, Inc. 3.60
    RLAY F Relay Therapeutics, Inc. 6.68
    KRON F Kronos Bio, Inc. -0.98
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Cancer Protein Kinase Inhibitor Enzymes Biopharmaceutical Biotechnology Tyrosine Kinase Receptors Fibroblast Growth Factor Receptor Solid Tumors Chemical Compounds Daiichi Sankyo Gastrointestinal Gastrointestinal Stromal Tumor Mastocytosis Non Small Cell Lung Cancer Receptor Tyrosine Kinase Small Molecule Therapies Systemic Mastocytosis Treatment Of Cancer Tyrosine Kinase Inhibitors Tyrosine Kinases

    Related ETFs - A few ETFs which own one or more of the above listed Tyrosine Kinase stocks.

    Symbol Grade Name Weight
    PBE B PowerShares Dynamic Biotech & Genome 6.1
    BBP C BioShares Biotechnology Products Fund 5.95
    IDNA B iShares Genomics Immunology and Healthcare ETF 5.74
    CNCR D Loncar Cancer Immunotherapy ETF 5.19
    XBI C SPDR S&P Biotech ETF 4.69
    View all Tyrosine Kinase ETFs...
    Compare ETFs
    Compare IDNA to XBI Compare PBE to IDNA Compare PBE to XBI

        Tyrosine Kinase Stocks Recent News

        Date Stock Title
        May 14 BPMC Blueprint Medicines started at buy by Stephens, citing Ayvakit franchise
        May 14 NRIX Nurix Therapeutics Announces Upcoming Oral Presentation of New Data from Ongoing Clinical Trial of NX-5948, a Selective Bruton’s Tyrosine Kinase (BTK) Degrader, at the European Hematology Association Congress (EHA2024)
        May 14 BBIO BridgeBio Pharma to Participate in the Bank of America Merrill Lynch Global Healthcare Conference 2024
        May 13 RLAY Relay Therapeutics to Host New Program and Platform Event on June 6, 2024
        May 13 COGT We Think Cogent Biosciences (NASDAQ:COGT) Can Afford To Drive Business Growth
        May 13 BBIO BridgeBio Pharma Presents Additional Data and Analyses from its Phase 3 ATTRibute-CM Study in Transthyretin Amyloid Cardiomyopathy (ATTR-CM) at ESC-HF, Including That Acoramidis Treatment Significantly Reduced All-Cause Mortality in a Pre-specified Sen...
        May 12 EXEL Billionaire Jim Simons Owns These 2 Healthcare Stocks: Should You?
        May 12 BBIO Cantor picks 14 undervalued biotech stocks worth a second look
        May 11 EXEL Exelixis files patent suit against India’s Cipla over Cabometyx generics
        May 10 RLAY Key Takeaways From Relay Therapeutics Analyst Ratings
        May 10 RIGL Rigel (RIGL) Upgraded to Buy: Here's What You Should Know
        May 10 RLAY Relay Therapeutics upgraded by Barclays ahead of data readout
        May 10 KRON Kronos Bio GAAP EPS of -$0.50 misses by $0.08, revenue of $2.52M
        May 10 RIGL Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Analysts Are Pretty Bullish On The Stock After Recent Results
        May 9 KRON Kronos Bio, Inc. (KRON) Reports Q1 Loss, Tops Revenue Estimates
        May 9 KRON Kronos Bio Reports First-Quarter 2024 Financial Results
        Related Industries: Biotechnology
        Related Stock Lists: Cancer Protein Kinase Inhibitor Enzymes Biopharmaceutical Biotechnology Tyrosine Kinase Receptors Fibroblast Growth Factor Receptor Solid Tumors Chemical Compounds Daiichi Sankyo Gastrointestinal Gastrointestinal Stromal Tumor Mastocytosis Non Small Cell Lung Cancer Receptor Tyrosine Kinase Small Molecule Therapies Systemic Mastocytosis Treatment Of Cancer Tyrosine Kinase Inhibitors Tyrosine Kinases
        Tyrosine Kinase

        Tyrosine kinase is an enzyme that catalyzes the transfer of phosphate groups from ATP to tyrosine residues on proteins. It is involved in many cellular processes, including cell growth, differentiation, and migration. Tyrosine kinases are also involved in signal transduction pathways, which are important for cell communication and regulation. Mutations in tyrosine kinases can lead to cancer and other diseases.

        Browse All Tags